How does psilocybin compare to LSD?

Psilocybin produces a shorter experience (4–6 hours) that is often described as more introspective and emotionally warm, while LSD typically lasts 8–12 hours and tends to feel more stimulating and cerebral.

What is the difference between psilocybin and psilocin?

Psilocybin is the prodrug found in mushrooms; the body converts it to psilocin, which is the active compound that binds to serotonin receptors and produces psychedelic effects.

How do therapeutic doses compare to recreational doses?

Clinical trials typically use 25 mg of synthetic psilocybin (roughly equivalent to 3–5 g of dried mushrooms); recreational doses vary widely but often fall in the 1–3.5 g range for moderate effects.

Substance Comparisons

Introduction

Psilocybin mushrooms are one of several psychedelic substances being researched for therapeutic potential. Understanding how they compare to other substances helps inform decisions about use, research, and therapeutic applications. This guide provides objective comparisons based on current scientific understanding.

Psilocybin vs. LSD

Similarities

Both are classic psychedelics with similar mechanisms of action
Both act primarily on 5-HT2A serotonin receptors
Similar therapeutic potential for depression, anxiety, and addiction
Both can produce mystical-type experiences

Differences

Duration: LSD lasts 8-12 hours; psilocybin 4-6 hours
Onset: LSD 30-60 min; psilocybin 20-60 min
Nature: LSD more stimulating; psilocybin more introspective
Source: LSD synthetic; psilocybin natural
Dosage: LSD measured in micrograms; psilocybin in grams

Psilocybin vs. MDMA

Key Differences

Mechanism: MDMA primarily releases serotonin; psilocybin is a serotonin agonist
Effects: MDMA is more empathogenic; psilocybin more psychedelic
Duration: MDMA 3-6 hours; psilocybin 4-6 hours
Therapeutic Use: MDMA for PTSD; psilocybin for depression/anxiety
Safety Profile: Both relatively safe when used responsibly

Psilocybin vs. DMT/Ayahuasca

Comparisons

Duration: DMT 15-30 min; Ayahuasca 4-6 hours; Psilocybin 4-6 hours
Intensity: DMT extremely intense; Ayahuasca very intense; Psilocybin moderate to intense
Traditional Use: Both have long histories of traditional use
Nature: DMT/Ayahuasca often more visual; Psilocybin more emotional/introspective

Psilocybin vs. Ketamine

Key Differences

Mechanism: Ketamine is an NMDA antagonist; psilocybin is a serotonin agonist
Effects: Ketamine is dissociative; psilocybin is psychedelic
Medical Use: Ketamine is FDA-approved for depression; psilocybin is in trials
Duration: Ketamine 1-2 hours; psilocybin 4-6 hours
Administration: Ketamine often IV/IM; psilocybin oral

Psilocybin vs. Cannabis

Comparisons

Intensity: Cannabis mild to moderate; psilocybin moderate to intense
Mechanism: Cannabis acts on endocannabinoid system; psilocybin on serotonin
Duration: Cannabis 2-4 hours; psilocybin 4-6 hours
Safety: Both relatively safe; cannabis more commonly used
Legal Status: Cannabis more widely legalized

Microdosing Comparisons

Psilocybin Microdosing

0.1-0.5g dried, every 2-3 days. Sub-perceptual effects, mood enhancement, creativity boost.

LSD Microdosing

5-20 micrograms, every 2-3 days. Similar benefits, potentially more stimulating.

Comparison

Both show similar reported benefits. Individual preference varies. LSD microdoses last longer (8-12 hours vs 4-6 hours).

Therapeutic Potential Comparison

Depression

Psilocybin: Strong evidence, rapid and sustained antidepressant effects
Ketamine: FDA-approved, rapid but short-lived effects
MDMA: Less direct for depression, more for PTSD

Anxiety

Psilocybin: Strong evidence for end-of-life anxiety, generalized anxiety
MDMA: Effective for social anxiety in therapeutic settings
Ketamine: Some evidence for anxiety disorders

Addiction

Psilocybin: Strong evidence for alcohol, tobacco, and other addictions
Ibogaine: Very effective but higher risk profile
Ayahuasca: Some evidence for addiction treatment

Safety Profile Comparison

Physical Safety

Psilocybin has an excellent safety profile with no known lethal dose in humans. Similar to LSD and MDMA in terms of physical safety when used responsibly.

Psychological Safety

All psychedelics carry risk of difficult experiences. Proper set, setting, and support are crucial. Psilocybin may be slightly gentler than some other substances for some users.

Legal Status Comparison

Legal status varies by jurisdiction. Psilocybin is being decriminalized in some areas and approved for research/therapy in others. Compare with other substances' legal status in your region.

Disclaimer

These comparisons are for educational purposes only. Individual responses vary significantly. Always prioritize safety, legality, and proper medical guidance. This information should not replace professional medical advice.